Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.52 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.52 |
| ▸ | IAPP | P10997 | 4/20 | 0.47 |
| ▸ | BID | P55957 | 3/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.45 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.45 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.45 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
| ▸ | EP300 | Q09472 | 1/20 | 0.45 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.45 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.45 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.45 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | CTSG | P08311 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31290573 | 0.89 | IAPP (0.44) | GABRA1GABRB2IAPPBIDMCL1 | |
| SCHEMBL218408 | 0.89 | IAPP (0.44) | GABRA1GABRB2IAPPBIDMCL1 | |
| SCHEMBL982521 | 0.88 | BID (0.50) | GABRA1GABRB2IAPPBIDMCL1 | |
| SCHEMBL980887 | 0.86 | BID (0.57) | GABRA1GABRB2IAPPBIDMCL1 | |
| SCHEMBL1796696 | 0.86 | IAPP (0.42) | GABRA1GABRB2IAPPBIDMCL1 | |
| SCHEMBL981302 | 0.85 | BID (0.59) | IAPPBIDMCL1BCL2L1BAK1 | |
| SCHEMBL983628 | 0.85 | BID (0.59) | IAPPBIDMCL1BCL2L1BAK1 | |
| SCHEMBL984542 | 0.85 | BID (0.59) | IAPPBIDMCL1BCL2L1BAK1 | |
| SCHEMBL981550 | 0.85 | BID (0.59) | IAPPBIDMCL1BCL2L1BAK1 | |
| SCHEMBL984316 | 0.85 | BID (0.59) | IAPPBIDMCL1BCL2L1BAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132049-A1 | METHOD FOR PRODUCING IRON OXIDE MAGNETIC PARTICLES, AND IRON OXIDE MAGNETIC PARTICLES FORMED THEREFROM | ZTI BIOSCIENCES CO LTD (KR) | 2026-05-14 | — | — | US | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| WO-2024080664-A1 | METHOD FOR PRODUCING IRON OXIDE BASED NANOPARTICLES, AND IRON OXIDE BASED NANOPARTICLES FORMED THEREFROM | 주식회사 지티아이바이오사이언스 | 2024-04-18 | — | — | WO | disclosed |
| CN-113929866-B | Modified resin and resin composition | 旭化成株式会社 | 2023-07-07 | — | — | CN | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| CN-111320562-B | Method for producing isothiocyanate | 旭化成株式会社 | 2022-08-16 | — | — | CN | disclosed |
| US-20220213075-A1 | 3-ARYLOXY-3-FIVE-MEMBERED HETEROARYL PROPYLAMINE COMPOUND, AND CRYSTAL FORM AND USE THEREOF | SHANGHAI LEADO PHARMATECH CO. LTD. (CN) | 2022-07-07 | — | — | US | disclosed |
| CN-111205424-B | Modified resin and resin composition | 旭化成株式会社 | 2022-04-08 | — | — | CN | disclosed |
| CN-113929866-A | Modified resin and resin composition | 旭化成株式会社 | 2022-01-14 | — | — | CN | disclosed |
| US-4448931-A | WITH RUBBER-MODIFIED POLYSTYRENE, SPECIFIC PARTICLE SIZE DISTRIBUTION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1984-05-15 | — | — | US | disclosed |
| EP-0099231-A2 | Polyphenylene ether resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1984-01-25 | — | — | EP | disclosed |
| EP-0099230-A1 | Polyphenylene ether resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1984-01-25 | — | — | EP | disclosed |
| US-4427814-A | DIPHOSPHONITE STABILIZER | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1984-01-24 | — | — | US | disclosed |
| EP-0083839-A2 | Process for producing inorganic fiber | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-07-20 | — | — | EP | disclosed |
| US-4383066-A | Polyphenylene ether resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1983-05-10 | — | — | US | disclosed |
| US-4341879-A | Polyphenylene ether resin composition having improved heat stability and impact strength | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1982-07-27 | — | — | US | disclosed |
| US-4308180-A | TIRE TREADS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-12-29 | — | — | US | disclosed |
| EP-0038183-A1 | Polyphenylene ether resin compositions and shaped articles thereof | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1981-10-21 | — | — | EP | disclosed |
| EP-0036278-A1 | Polyphenylene ether resin composition of improved heat stability and shaped articles thereof | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1981-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213075-A1 | 3-ARYLOXY-3-FIVE-MEMBERED HETEROARYL PROPYLAMINE COMPOUND, AND CRYSTAL FORM AND USE THEREOF | TRPM5, TRPV5, TRPM7 | GABRA1 1192/4885GABRB2 1764/4885IAPP 1790/4885 |
| US-20260132049-A1 | METHOD FOR PRODUCING IRON OXIDE MAGNETIC PARTICLES, AND IRON OXIDE MAGNETIC PARTICLES FORMED THEREFROM | FASN, AIFM2, SFXN1 | GABRA1 2927/4885GABRB2 3624/4885IAPP 2772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.